...
首页> 外文期刊>Acta medica Okayama >Zerobot?: A Remote-controlled Robot for Needle Insertion in CT-guided Interventional Radiology Developed at Okayama University
【24h】

Zerobot?: A Remote-controlled Robot for Needle Insertion in CT-guided Interventional Radiology Developed at Okayama University

机译:Zerobot ?:冈山大学开发的CT引导介入放射学中用于插针的遥控机器人

获取原文
           

摘要

Since 2012, we have been developing a remote-controlled robotic system (Zerobot?) for needle insertion during computed tomography (CT)-guided interventional procedures, such as ablation, biopsy, and drainage. The system was designed via a collaboration between the medical and engineering departments at Okayama University, including various risk control features. It consists of a robot with 6 degrees of freedom that is manipulated using an operation interface to perform needle insertions under CT-guidance. The procedure includes robot positioning, needle targeting, and needle insertion. Phantom experiments have indicated that robotic insertion is equivalent in accuracy to manual insertion, without physician radiation exposure. Animal experiments have revealed that robotic insertion of biopsy introducer needles and various ablation needles is safe and accurate in vivo. The first in vivo human trial, therefore, began in April 2018. After its completion, a larger clinical study will be conducted for commercialization of the robot. This robotic procedure has many potential advantages over a manual procedure: 1) decreased physician fatigue; 2) stable and accurate needle posture without tremor; 3) procedure automation; 4) less experience required for proficiency in needle insertion skills; 5) decreased variance in technical skills among physicians; and 6) increased likelihood of performing the procedure at remote hospitals (i.e., telemedicine).
机译:自2012年以来,我们一直在开发一种远程控制的机器人系统(Zerobot?),用于在计算机断层扫描(CT)指导下的介入程序(例如消融,活检和引流)中插入针头。该系统是通过冈山大学医学与工程部门之间的协作设计的,包括各种风险控制功能。它由一个具有6个自由度的机器人组成,该机器人可通过操作界面进行操作,以在CT引导下进行针头插入。该过程包括机器人定位,针头瞄准和针头插入。幻影实验表明,在没有医生辐射的情况下,机器人插入的准确性与手动插入相当。动物实验表明,在活体内自动插入活检导引针和各种消融针是安全和准确的。因此,首次体内人体试验于2018年4月开始。完成后,将进行更大范围的临床研究,以使机器人商业化。与手动程序相比,这种机器人程序具有许多潜在的优势:1)减轻了医生的疲劳; 2)稳定,准确的针位姿势,无震颤; 3)程序自动化; 4)熟练掌握插针技巧所需的经验较少; 5)减少医生之间技术技能的差异;和6)在偏远医院(即远程医疗)执行该程序的可能性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号